Kwality Pharmaceuticals Ltd (KPL) — Board Meeting | 2 September 2026
Kwality Pharmaceuticals announced at its August 31, 2026 AGM the regularization of Mr. Swanith Kapoor’s appointment as Non-Executive Independent Director for five years until June 1, 2031, and the reappointment of Mr. Aditya Arora as Whole Time Director for five years until September 29, 2031. Both appointments were approved by shareholders and are now disclosed under SEBI Listing Regulations.
About Kwality Pharmaceuticals Ltd (KPL)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when KPL files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track KPL — Free💡 Ask AI about this filing
📊 More KPL filings
- Announcement — 28 September 2026Kwality Pharmaceuticals Ltd announced that its trading window will close on October 1, 2026, remaini...
- 🟡 Board Meeting — 31 August 2026Kwality Pharmaceuticals held its 43rd AGM on August 31, 2026 via video conference, with all director...
- 🟡 concall transcript — 30 June 2026Kwality Pharmaceuticals reported Q1 FY27 results with oncology revenue at 20% of total, down from 26...
- 🟡 concall transcript — 31 March 2026Kwality Pharmaceuticals reported FY26 revenue of INR503 crores (up 36% YoY) and PAT of INR67 crores ...
🔥 Also filed on 2 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when KPL files new disclosures
Track KPL filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track KPL — FreeFree account · 2 AI queries/day